Literature DB >> 5322445

The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study.

I Sarkany, J W Hadgraft, G A Caron, C W Barrett.   

Abstract

Mesh:

Substances:

Year:  1965        PMID: 5322445     DOI: 10.1111/j.1365-2133.1965.tb14577.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  Desoxymethasone: a review of its pharmacological properties and therapeutic efficacy in the treatment of dermatoses.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

2.  [In vitro-penetration of radiolabelled hydrocortisone in various vehicles in human skin (author's transl)].

Authors:  A Zesch; H Schaefer
Journal:  Arch Dermatol Forsch       Date:  1973-05-28

3.  Hydrocortisone butyrate penetration through epidermis in vitro. Influence of vehiculum, connectration in the vehiculum, and the amount applied.

Authors:  M Ponec; M K Polano
Journal:  Arch Dermatol Forsch       Date:  1972

4.  Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.

Authors:  E Rampini; A Rastelli; P Cardo
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

5.  Treatment of atopic eczema.

Authors:  I Sneddon
Journal:  Br Med J       Date:  1966-12-10

6.  [Is the vasoconstrictor test suitable for comparing the effect of locally applied corticosteroids? An experimental study].

Authors:  H Zaun
Journal:  Arch Klin Exp Dermatol       Date:  1966

Review 7.  Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

Authors:  M Mori; N Pimpinelli; B Giannotti
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

8.  Failure of topical acyclovir in ointment to penetrate human skin.

Authors:  D J Freeman; N V Sheth; S L Spruance
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.